The calcification of heart valves is currently resolved by transplanting a new prosthetic valve (see above). Israel’s Pi-Cardia (see here previously) has been developing the Leaflex system to treat the calcification, and is currently conducting human clinical trials across Europe. … Continue reading →

Israel’s Pi-Cardia has developed the Leaflex Catheter System – a novel non-implant based technology for treating patients with aortic valve stenosis, rather than replacing the heart valve. Pi-Cardia has just raised $10 million to help complete development of a second-generation … Continue reading →